Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Neuromuscular Block in Obese Gastric Cancer Patients
NCT03196791Phase 3Completed
- Sponsor
- Korea University Anam Hospital
- Start
- Oct 2017
- Primary completion
- Aug 2020
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sugammadex in gastric cancer (GC), sponsored by Korea University Anam Hospital. Started Oct 2017; status: completed.
02
Drugs
Sugammadex
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03196791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03196791.